World's Best Scientists 2026 revealed!
Dominick J. Angiolillo

Dominick J. Angiolillo

D-Index & Metrics

Medicine

D-Index
122
Citations
61369
World Ranking
3447
National Ranking
1895

Dominick J. Angiolillo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dominick J. Angiolillo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,000 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dominick J. Angiolillo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dominick J. Angiolillo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dominick J. Angiolillo is affiliated with the University of Florida in the United States and has contributed extensively to medical research, particularly in cardiology and cardiovascular medicine. Their body of work encompasses a wide range of topics within the field of medicine, with a strong focus on antiplatelet therapy and cardiovascular diseases.

They have authored or co-authored research papers, including notable recent publications such as:

  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, 2020, European Heart Journal
  • The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease, 2020, Thrombosis and Haemostasis
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention, 2021, Circulation
  • Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19, 2021, JAMA
  • P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials, 2021, BMJ

Their research spans several main fields and subfields, with over a thousand medical publications. Specifically, the subfields include cardiology and cardiovascular medicine, surgery, internal medicine, endocrinology, diabetes and metabolism, and radiology, nuclear medicine and imaging.

Dominick J. Angiolillo's research focuses on topics such as:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management

The researcher has collaborated frequently with other scholars in their field. Regular co-authors include Roxana Mehran, Mattía Galli, Davide Capodanno, Francesco Franchi, and Deepak L. Bhatt.

Dominick J. Angiolillo's work has been published predominantly in leading cardiovascular journals, including:

  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • European Heart Journal
  • European Heart Journal - Cardiovascular Pharmacotherapy
  • Circulation

In addition to articles, Dominick J. Angiolillo has contributed to the field through book publications, with titles such as Precision Medicine for Antithrombotic Therapy in Patients after Percutaneous Coronary Interventions, published by Frontiers Media in 2023.

Best Publications

  • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Jean-François Tanguay

  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Dominick J. Angiolillo

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk

    Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo

  • Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.

    Stephen D. Wiviott;Dietmar Trenk;Andrew L. Frelinger;Michelle O’Donoghue

  • Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future Perspectives

    Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Fernando Alfonso

  • Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

    Stephen D. Wiviott;Eugene Braunwald;Dominick J. Angiolillo;Simha Meisel

  • Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  • Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

    Deepak L. Bhatt;Gregg W. Stone;Kenneth W. Mahaffey;C. Michael Gibson

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.

    Dietmar Trenk;Gregg W. Stone;Meinrad Gawaz;Adnan Kastrati

  • Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

    Raúl Moreno;Cristina Fernández;Rosana Hernández;Fernando Alfonso

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

    Stefanie Schüpke;Franz-Josef Neumann;Maurizio Menichelli;Katharina Mayer

  • Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.

    Dominick J. Angiolillo;Steven B. Shoemaker;Bhaloo Desai;Hang Yuan

  • Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

    Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Celia Ramírez

  • Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.

    Dominick J. Angiolillo;Michael S. Firstenberg;Matthew J. Price;Pradyumna E. Tummala

  • Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

    Manel Sabaté;Pilar Jiménez-Quevedo;Dominick J. Angiolillo;Joan Antoni Gómez-Hospital

  • Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.

    Matthew J. Price;Dominick J. Angiolillo;Paul S. Teirstein;Elizabeth Lillie

  • A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity

    D Trenk;GW Stone;M Gawaz;A Kastrati

Frequent Co-Authors

Davide Capodanno
Davide Capodanno University of Catania
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Carlos Macaya
Carlos Macaya Complutense University of Madrid
Fernando Alfonso
Fernando Alfonso Hospital Universitario de La Princesa
Manel Sabaté
Manel Sabaté University of Barcelona
Javier Escaned
Javier Escaned Hospital Clínico San Carlos
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Paul A. Gurbel
Paul A. Gurbel Inova Fairfax Hospital
Robert F. Storey
Robert F. Storey University of Sheffield
Marco Valgimigli
Marco Valgimigli University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are flexible online degree options that can open new career pathways in healthcare. One common concern is cost—if you’re wondering how much is online nursing school, you'll find that tuition can vary widely. Many programs cater to working adults and offer affordable options.

Registered nurses looking to advance their education often pursue bridge programs. If this is you, researching rn to bsn online cost is important, since tuition may differ based on state, transfer credits, and program length.

For those considering leadership roles or academia, online phd programs nursing offer a convenient path to a terminal degree that fits around professional responsibilities. Meanwhile, career changers without a nursing background may be interested in online msn programs for non nurses, which provide an accelerated path to advanced practice nursing.

Online healthcare degrees can accommodate different career goals, experience levels, and budgets—making medical careers more accessible than ever.

Best Scientists Citing Dominick J. Angiolillo

Trending Scientists

Recently Published Articles